Dasgupta S, Imamura M, Gorstein E, Nakahara T, et al. Modeling-based response-guided therapy for chronic hepatitis C under glecaprevir/pibrentasvir may identify patients for ultra-short treatment duration. J Infect Dis 2020 May 4. pii: 5828592. doi: 10.1093.
PMID: 32363394